Hemab

Acquisition, funding and merger involving Hemab.

• Hemab has just announced a $135 Million fundraising (posted on February 23 2023).

View the org chart displaying its 11 main executives

Most searched biographies at Hemab

• Benny Sorensen, Chief Executive Officer and Director
• Laura Tadvalkar​, Director
• Uya Chuluunbaatar, Director

Create your alert
to follow the executive moves at Hemab.

Hemab has 2,291 competitors including Lonza (Switzerland), Eurofins (Luxembourg) and Adaptive Phage Therapeutics (United States (USA)).

Popular M&A news in Biotechnology

• Lycia Therapeutics has just announced a $107 Million fundraising (posted on May 15 2024).
• Attovia Therapeutics has just announced a $150 Million fundraising (posted on May 14 2024).
• Bruker has announced the acquisition of NanoString Technologies  (posted on May 13 2024).

Popular contacts in Biotechnology

• Ali Behbahani - Non-Executive Director at Adaptimmune Therapeutics
• Carl Gordon - Director at Adicet Bio
• Vik Bajaj - Director at Interline Therapeutics

Learn more about the Biotechnology industry >

Press releases by Hemab

Social media about Hemab

• Hemab on Wikipedia, Google News & Yahoo Finance
• Hemab on LinkedIn, Twitter & YouTube

Contact by email its executives including Benny Sorensen

Call Hemab at +45 732...

View the org chart

Register to receive your alert

Report an error